CAS: 35444-44-1; Methyl 6-Chloro-6-Oxohexanoate

相似化合物

41624-92-4 1501-26-4 1490-25-1

上下游产品

CAS号627-91-8 己二酸单甲酯 | CAS号79-37-8 草酰氯 | CAS号627-93-0 己二酸二甲酯 | CAS号1501-27-5 戊二酸单乙酯 | CAS号124-04-9 己二酸 | CAS号502-44-3 ε-己内酯 | CAS号4547-43-7 6-羟基己酸甲酯 | CAS号108-55-4 戌二酸酐 | CAS号67-56-1 甲醇 | CAS号111-50-2 己二酰氯 | CAS号557-61-9 1-二十八烷醇 | CAS号55682-92-3 甲基二十八酸酯 | CAS号4144-62-1 5-苯甲酰基戊酸 | CAS号142319-48-0 6-oxo-6-[(4-sul... | CAS号141023-00-9 7,7,7-三氟-6-氧代庚酸甲酯 | CAS号191655-19-3 methyl 5-(4,5-d... | CAS号2380-21-4 6-Oxo°Ctadecano... | CAS号2955-61-5 methyl 6-oxo°Ct... | CAS号2181-97-7 (甲氧基羰基甲基)三苯基氯化鏻 | CAS号79293-72-4 1,6-Dimethoxyca...

📜6-羟基己酸甲酯置于chromium(Vi) Oxide,草酰氯,硫酸,N,N-二甲基甲酰胺体系中,用 二氯甲烷,水,丙酮 用作溶剂,化学反应 17.67H,反应生成甲基脂肪酰氯
参考文献:Binns,Falmai; Roberts,Stanley M.; Taylor,Alan,Journal Of The Chemical Society. Perkin Transactions I,1993,# 8,P. 899-904
标题:Binns,Falmai; Roberts,Stanley M.; Taylor,Alan,Journal Of The Chemical Society. Perkin Transactions I,1993,# 8,P. 899-904

专利信息

专利号:US-5216005-A
优先权日:1989-03-15
标题:Immunosuppressive analogues and derivatives of succinylacetone
发明人：NITECKI DANUTE E; ALDWIN LOIS; LEVENSON COREY H; MORELAND MARGARET; BRAUDE IRWIN; MARK DAVID F; RAPOPORT HENRY
权利人:CETUS CORP
摘要:Succinylacetone derived or related medicaments and methods of synthesis of the same are shown wherein the medicaments consists of succinylacetonyl-proline-PEG, succinylacetonyl-NH-PEG, or compounds that have the formula: wherein n = 1-6 RIV = H, or alkyl and that have immunosuppressive activity both in vivo and in vitro based on their activities in cellular immunologic assays and adjuvant induced arthritis in rats, respectively.

专利号:US-5173482-A
优先权日:1989-03-15
标 题 :Immunosuppressive analogues and derivatives of succinylacetone
发明人：NITECKI DANUTE E; MORELAND MARGARET; ALDWIN LOIS; LEVENSON COREY H; BRAUDE IRWIN; MARK DAVID F; RAPOPORT HENRY
权利人:CETUS CORP
摘要:Succinylacetone derived or related medicaments and methods of synthesis of the same are shown wherein the medicaments consists of succinylacetonyl-proline-PEG, succinylacetonyl-NH-PEG, or compounds that have the formula: wherein n = 1-6 RIV = H, or alkyl and that have immunosuppressive activity both in vivo and in vitro based on their activities in cellular immunologic assays and adjuvant induced arthritis in rats, respectively.

专利号:US-4895872-A
优先权日:1989-03-15
标题:Immunosupressive analogues and derivatives of succinylacetone
发明人：NITECKI DANUTE E; MORELAND MARGARET; ALDWIN LOIS; LEVENSON COREY H; BRAUDE IRWIN; MARK DAVID F; RAPAPORT HENRY
权利人:CETUS CORP
摘要:Succinylacetone derived or related medicaments and methods of synthesis of the same are shown wherein the medicaments consists of succinylacetonyl-proline-PEG, succinylacetonyl-NH-PEG, or compounds that have the formula: wherein n = 1-6 RIV = H, or alkyl and that have immunosuppressive activity both in vivo and in vitro based on their activities in cellular immunologic assays and adjuvant induced arthritis in rats, respectively.

专利号:US-5252603-A
优先权日:1989-03-15
标题 :Immunosuppressive analogues and derivatives of succinylacetone
发明人：NITECKI DANUTE E; ALDWIN LOIS; LEVENSON COREY H; MORELAND MARGARET; BRAUDE IRWIN; MARK DAVID F; RAPOPORT HENRY
权利人:CETUS CORP
摘要:Succinylacetone derived or related medicaments and methods of synthesis of the same are shown wherein the medicaments consists of succinylacetonyl-proline-PEG, succinylacetonyl-NH-PEG, or compounds that have the formula: wherein n=1-6 R=CH3, CF3, -CO2RIV, RI, RII=H, F, CH3, or RIII=H, or tetrazolyl RIV=H, or alkyl and that have immunosuppressive activity both in vivo and in vitro based on their activities in cellular immunologic assays and adjuvant induced arthritis in rats, respectively.

专利号:US-9402842-B2
优先权日:2012-04-13
标题:Synthesis and use of dual tyrosyl-DNA phosphodiesterase I (Tdp1)—topoisomerase I (Top1) inhibitors
发明人：CUSHMAN MARK S; NGUYEN TRUNG X; CONDA-SHERIDAN MARTIN M; POMMIER YVES GEORGE
权利人:PURDUE RESEARCH FOUNDATION
摘要:The invention described herein pertains to the synthesis and use of certain N-substituted indenoisoquinoline compounds which inhibit the activity Tyrosyl-DNA Phosphodiesterase I (Tdp1) or Topoisomerase I (Top1) or both, or otherwise demonstrate anticancer activity. Also disclosed are novel N-substituted indenoisoquinoline compounds and pharmaceutical compositions comprising the novel N-substituted indenoisoquinoline compounds.

专利号:US-4054740-A
优先权日:1974-12-24
标 题 :Hydroxybiotin
发明人：FIELD GEORGE FRANCIS
权利人:HOFFMANN LA ROCHE
摘要:This invention relates to a synthesis of biotin by the reduction of dehydrobiotin. The dehydrobiotin is prepared from 6-hydroxy-7-nitro-heptanoic acid methyl ester. Novel intermediates are also obtained by this synthesis.